We are live on ! Find out more
MTEM

Molecular Templates, Inc.
MTEM

Delisted

MTEM was delisted on the 24th of December, 2024.

Back to rankings

3 hedge funds and large institutions have $4 invested in Molecular Templates, Inc. in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% less funds holding

Funds holding: 24 → 3 (-21)

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 22

100% less capital invested

Capital invested by funds: $4.35M → $4 (-$4.35M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-21
Holders Change %
-87.5%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CIAS
CBIZ Investment Advisory Services
Ohio
+$3

Top Sellers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
-$1.8M
2
SCM
Silverarc Capital Management
Massachusetts
-$876K
3
BI
BVF Inc
California
-$734K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$642K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$71.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
Barclays
1
Barclays
United Kingdom
$4 -$216 -373 -79%
BG
2
Bellevue Group
Switzerland
– -$1.8M -1,279,820 Closed
SCM
3
Silverarc Capital Management
Massachusetts
– -$876K -623,838 Closed
BI
4
BVF Inc
California
– -$734K -522,238 Closed
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
– -$642K -73,125 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$71.5K -50,899 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
– -$66.4K -47,231 Closed
BlackRock
8
BlackRock
New York
– -$53.6K -38,130 Closed
I
9
INVST
Indiana
– -$32.9K -23,400 Closed
Renaissance Technologies
10
Renaissance Technologies
New York
– -$19.7K -14,053 Closed
State Street
11
State Street
Massachusetts
– -$19.2K -13,676 Closed
CG
12
Carlyle Group
District of Columbia
– -$18.7K -13,333 Closed
Morgan Stanley
13
Morgan Stanley
New York
– -$7.31K -5,201 Closed
PP
14
PFS Partners
New Jersey
– -$4.68K -3,333 Closed
TRCT
15
Tower Research Capital (TRC)
New York
– -$4.54K -3,231 Closed
Osaic Holdings
16
Osaic Holdings
Arizona
– -$496 -354 Closed
Bank of America
17
Bank of America
North Carolina
– -$380 -271 Closed
JP Morgan Chase
18
JP Morgan Chase
New York
– -$52 -37 Closed
AIM
19
Arcadia Investment Management
Michigan
– -$9 -6 Closed
TIM
20
Tortoise Investment Management
New York
– -$8 -6 Closed
AF
21
Allworth Financial
California
– -$3 -2 Closed
UBS Group
22
UBS Group
Switzerland
– -$1 -1 Closed
CIAS
23
CBIZ Investment Advisory Services
Ohio
– +$3 +6 New

MTEM Hedge Fund Activity: Q4 2024 in Review

3 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Molecular Templates, Inc. (MTEM) for Q4 2024, worth a combined $4 — down 100% from $4.35M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of MTEM and 1 opened new positions — a net loss of 21 holders — while 1 trimmed existing stakes and 0 added.

The largest buyer was CBIZ Investment Advisory Services, opening a new position worth an estimated $3. The largest seller was Bellevue Group, exiting entirely with an estimated $1.8M sold.

  • 3 institutional investors held Molecular Templates, Inc. (MTEM) as of Q4 2024, down from 24 in Q3 2024.
  • Funds reported $4 of Molecular Templates, Inc. stock for Q4 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Molecular Templates, Inc. positions in Q4 2024 and 22 closed out, a net change of -21 holders.
  • The largest Molecular Templates, Inc. buyer in Q4 2024 was CBIZ Investment Advisory Services, an estimated $3 added.
  • The largest Molecular Templates, Inc. seller in Q4 2024 was Bellevue Group, an estimated $1.8M sold.

Based on aggregated 13F filings for Q4 2024.